UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example Bundle: CefStragen-250mg-Powder-SE-IS-MPD-BBDL

Cefuroxim Stragen 250 mg Pulver till injektionsvätska, lösning

MPID: SE-100002835-00021952
EURDID: 615

Full name: Cefuroxim Stragen 250 mg Pulver till injektionsvätska, lösning

- Invented name part: Cefuroxim Stragen

- Strength part: 250 mg

- Pharmaceutical dose form part: pulver till injektionsvätska, lösning

Name usage: Swedish (Kingdom of Sweden)

Authorised dose form: Powder for solution for injection

Legal status of supply: Medicinal product subject to medical prescription

Domain: Human use

Resource status: Current

Product classification:

  • 100000093533 J01DC02

Marketing Authorisation 1 of 1

Authorisation number: 21952

Region: Kingdom of Sweden

Marketing authorisation holder: Stragen Nordic A/S

Identifier:

  • LOC-100001098

Status: Valid (2005-06-23)

Package 1 of 1

PCID:

Description:
Injektionsflaska, 10 st (10 x 250 mg)

Marketing status:

  • Kingdom of Sweden: Marketed

Pack size:

  • 10 Vial

Package: 1 Box (Cardboard)

Containing:

Package: 10 Vial (Glass)

Containing: 10 Vial

Manufactured Item

Dose form: Powder for solution for injection

Unit of presentation: Vial

Ingredient

Role: Active

Substance: cefuroxime sodium

Concentration strength: 263 milligram(s) / 1 unit(s)

Reference strength:
cefuroxime 250 milligram(s) / 1 unit(s)

Administrable Product (1 of 1)

Dose form: Solution for injection

Unit of presentation:

Route of administration:

  • Intramuscular use

Ingredients:

Ingredient

Role: Active

Substance: cefuroxime sodium

Concentration strength: 263 milligram(s) / 1 unit(s)

Reference strength:
cefuroxime 250 milligram(s) / 1 unit(s)